Mapping of the MRPm5 epitope to the cytosolic region between transmembrane helices 13 and 14 in the drug and organic anion transporter, MRP1 (ABCC1)

Biochemical and Biophysical Research Communications

Volumn 315, Issue 3, 2004, Pages 719-725

  Koike, Koji ^a,b   Deeley, Roger G ^a   Cole, Susan P C ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cytoplasmic loop; Epitope mapping; Membrane protein; Monoclonal antibody; MRP1; Multidrug resistance; Organic anion transporter

Indexed keywords

EPITOPE; LEUKOTRIENE C4; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN 1;

ANION TRANSPORT; ARTICLE; CYTOPLASM; CYTOSOL; EPITOPE MAPPING; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

MURINAE;

EID: 1242272844     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.111     Document Type: Article

References (34)

1. Borst P., Oude Elferink R.P.J. Mammalian membrane transporters in health and disease. Annu. Rev. Biochem. 71:2002;537-592.
2. Higgins C.F. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8:1992;67-113.
3. Cole S.P.C., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M.V., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
4. 2-terminus. J. Biol. Chem. 272:1997;23623-23630.
5. Bakos E., Hegedus T., Hollo Z., Welker E., Tusnady G.E., Zaman G.J.R., Flens M.J., Varadi A., Sarkadi B. Membrane topology and glycosylation of the human multidrug resistance associated protein. J. Biol. Chem. 271:1996;12322-12326.
6. A. Haimeur, G. Conseil, R.G. Deeley, S.P.C. Cole, The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation, Curr. Drug Metab. 5 (2004) in press.
7. Bates S.E. Solving the problem of multidrug resistance: ABC transporters in clinical oncology. Holland I.B., Cole S.P.C., Kuchler K., Higgins C.F. ABC Proteins: From Bacteria to Man. 2003;359-391 Elsevier, London.
8. 4 and structurally related conjugates. J. Biol. Chem. 269:1994;27807-27810.
9. 4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport. J. Biol. Chem. 271:1996;99675- 99682.
10. Wijnholds J., Evers R., van Leusden M.R., Mol C.A.A.M., Zaman G.J.R., Mayer U., Beijnen J.H., Van der Valk M., Krimpenfort P., Borst P. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance associated protein. Nat. Med. 3:1997;1275-1279.
11. r 190,000 multidrug resistance protein, MRP, with monoclonal antibodies Cancer Res. 54:1994;5788-5792.
12. Flens M.J., Izquierdo M.A., Scheffer G.L., Fritz J.M., Meijer C.J.L.M., Scheper R.J., Zaman G.J.R. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res. 54:1994;4557-4563.
13. Connolly L., Moran E., Larkin A., Scheffer G., Scheper R., Sarkadi B., Kool M., Clynes M. A new monoclonal antibody, P2A8(6), that specifically recognizes a novel epitope on the multidrug resistance-associated protein 1 (MRP1), but not on MRP2 nor MRP3. Hybridoma Hybridomics. 20:2001;333-341.
14. Scheffer G.L., Kool M., Heijn M., De Haas M., Pijnenborg A.C.L.M., Wijnholds J., Van Helvoort A., de Jong M.C., Hooijberg J.H., Mol C.A.A.M., Van der Linden M., de Vree J.J.L., Van der Valk P., Oude Elferink R.P.J., Borst P., Scheper R.J. Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. Cancer Res. 60:2000;5269-5277.
15. Chen Q., Yang Y., Liu Y., Han B., Zhang J.T. Cytoplasmic retraction of the amino terminus of human multidrug resistance protein 1. Biochemistry. 41:2002;9052-9062.
16. Hou Y.X., Cui L., Riordan J.R., Chang X.B. Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1. J. Biol. Chem. 275:2000;20280-20287.
17. Hipfner D.R., Almquist K.C., Stride B.D., Deeley R.G., Cole S.P.C. Location of a protease-hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1. Cancer Res. 56:1996;3307-3314.
18. Hipfner D.R., Gao M., Scheffer G., Scheper R.J., Deeley R.G., Cole S.P.C. Epitope mapping of monoclonal antibodies specific for the 190. kDa multidrug resistance protein, MRP Br. J. Cancer. 78:1998;1134-1140.
19. Hipfner D.R., Mao Q., Qiu W., Leslie E.M., Gao M., Deeley R.G., Cole S.P.C. Monoclonal antibodies that inhibit the transport function of the 190-kDa multidrug resistance protein, MRP. J. Biol. Chem. 274:1999;15420-15426.
20. Cui L., Hou Y.X., Riordan J.R., Chang X.B. Mutations of the Walker B motif in the first nucleotide binding domain of multidrug resistance protein MRP1 prevent conformation maturation. Arch. Biochem. Biophys. 392:2001;53-61.
21. Renes J., de Vries E.G., Nienhuis E.F., Jansen P.L., Muller M. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. Br. J. Pharmacol. 126:1999;681-688.
22. Hooijberg J.H., Broxterman H.J., Scheffer G.L., Vrasdonk C., Heijn M., de Jon M.C., Scheper R.J., Lankelma J., Pinedo H.M. Potent interaction of flavopiridol with MRP1. Br. J. Cancer. 81:1999;269-276.
23. Flens M.J., Zaman G.J.R., van der Valk P., Izquierdo M.A., Schroeijers A.B., Scheffer G.L., Van der Groep P., de Haas M., Meijer C.J.L.M., Scheper R.J. Tissue distribution of the multidrug resistance-associated protein. Am. J. Pathol. 148:1996;1237-1247.
24. K. Koike, G. Conseil, E.M. Leslie, R.G. Deeley, S.P.C. Cole, Identification of proline residues in the core cytoplasmic and transmembrane regions of multidrug resistance protein 1 (MRP1/ABCC1) important for transport function, substrate specificity, and nucleotide interactions, J. Biol. Chem. 279 (2004) in press, epub ahead of print Jan. 13.
25. 1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. J. Biol. Chem. 276:2001;38108-38114.
26. 1242 of TM17 alters substrate specificity of human multidrug resistance protein, MRP3. Am. J. Physiol. 284:2003;G280-G289.
27. Ito K., Olsen S.L., Qiu W., Deeley R.G., Cole S.P.C. Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. J. Biol. Chem. 276:2001;15616-15624.
28. 4 transport by co-expression of both half-molecules of human MRP in insect Sf21 cells. J. Biol. Chem. 271:1996;27782-27787.
29. Daoud R., Desneves J., Deady L.W., Tilley L., Scheper R.J., Gros P., Georges E. The multidrug resistance protein is photoaffinity labeled by a quinoline-based drug at multiple sites. Biochemistry. 39:2000;6094-6102.
30. 125I]LY475776: evidence of a major binding site in the COOH-proximal membrane spanning domain. J. Biol. Chem. 277:2002;28690-28699.
31. Mao Q., Deeley R.G., Cole S.P.C. Functional reconstitution of substrate transport by purified multidrug resistance protein MRP1 (ABCC1) in phospholipid vesicles. J. Biol. Chem. 275:2000;34166-34172.
32. Zhang D., Gu H., Situ D., Haimeur A., Cole S.P.C., Deeley R.G. Functional importance of polar and charged amino acid residues in transmembrane helix 14 of multidrug resistance protein 1 (MRP1/ABCC1): identification of an aspartate residue critical for conversion from a high to low affinity substrate binding site. J. Biol. Chem. 278:2003;46052-46063.
33. Chang G. Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation. J. Mol. Biol. 330:2003;419-430.
34. 594 in transmembrane helix 11 of the multidrug resistance protein, MRP1 (ABCC1). J. Biol. Chem. 279:2004;463-468.